A carregar...
Engineering Chimeric Antigen Receptor T cells to Treat Glioblastoma
Immunotherapy has emerged as a promising strategy for glioblastoma (GBM), a disease that remains universally fatal despite currently available standard-of-care. Adoptive T cell therapy has been shown to produce potent antitumor immunity while obviating the need for traditional antigen presentation a...
Na minha lista:
| Publicado no: | J Target Ther Cancer |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5695679/ https://ncbi.nlm.nih.gov/pubmed/29167820 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|